top of page
Embryonic Stem Cells

ABTECH THERAPEUTICS

Evolving Biologics

Pipetting Samples

WHAT WE DO

Technologies Crossroad

We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. 

We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.

Male Scientist

OUR TECHNOLOGY

Synthetic biology meets directed evolution

We use synthetic antibody as a versatile and performant technology platform, that we combine with in silico and in vitro cutting edge technologies.  

 

GET IN TOUCH

Thanks for submitting!

©2022 by Abtech Therapeutics S.A.S. Capital social de 49000€; 180 avenue du Prado 13008 Marseille; enregistré au R.C.S. de Marseille 899 229 801. N° TVA: FR08899229801.  Publié par Frédéric Fellouse. 

bottom of page